|
|
||||||||
AJP - Endocrinology and Metabolism, Vol 260, Issue 3 E363-E370, Copyright © 1991 by American Physiological Society
ARTICLES |
R. W. Stevenson, K. E. Steiner, C. C. Connolly, H. Fuchs, K. G. Alberti, P. E. Williams and A. D. Cherrington
Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0615.
The effects of increases in plasma epinephrine from 78 +/- 32 to 447 +/- 75, 1,812 +/- 97, or 2,495 +/- 427 pg/ml on glucose production, including gluconeogenesis, were determined in the conscious, overnight-fasted dog, using a combination of tracer [( 3-3H]glucose and [U-14C]alanine) and arteriovenous difference techniques. Insulin and glucagon were fixed at basal levels using a pancreatic clamp. Plasma glucose levels rose during the 180-min epinephrine infusion by 47 +/- 7, 42 +/- 22, and 74 +/- 25 mg/dl, respectively, in association with increases in hepatic glucose output of 1.04 +/- 0.22, 1.87 +/- 0.23, and 3.70 +/- 0.83 mg.kg-1.min-1 (at 15 min). Blood lactate levels rose by 1.52 +/- 0.24, 4.29 +/- 0.49, and 4.60 +/- 0.45 mmol/l, respectively, by 180 min, despite increases in hepatic uptake of lactate of 3.47 +/- 5.73, 12.83 +/- 3.46, and 37.00 +/- 4.20 mumol.kg-1.min-1. The intrahepatic gluconeogenic efficiency with which the liver converted the incoming alanine to glucose had risen by 84 +/- 40, 77 +/- 24, and 136 +/- 34% at 180 min, respectively. The latter effect plus the effect on net hepatic lactate uptake point to an intrahepatic action of high levels of the hormone in vivo. In conclusion, epinephrine produces dose-dependent increments in overall glucose production, which involve a progressive stimulation of both glycogenolysis (as assessed by glucose production at 15 min) and gluconeogenesis (assessed in the last 30 min of the study). The latter involves a peripheral action of the catecholamine to increase gluconeogenic substrate supply to the liver and may also involve a hepatic effect when high epinephrine levels are present.
This article has been cited by other articles:
![]() |
C. Everett-Grueter, D. S. Edgerton, E. P. Donahue, S. Vaughan, C. A. Chu, D. K. Sindelar, and A. D. Cherrington The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E449 - E459. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Meyer, M. Stumvoll, S. Welle, H. J. Woerle, M. Haymond, and J. Gerich Relative importance of liver, kidney, and substrates in epinephrine-induced increased gluconeogenesis in humans Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E819 - E826. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Gustavson, C. A. Chu, M. Nishizawa, B. Farmer, D. Neal, Y. Yang, E. P. Donahue, P. Flakoll, and A. D. Cherrington Interaction of glucagon and epinephrine in the control of hepatic glucose production in the conscious dog Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E695 - E707. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Chu, P. Galassetti, K. Igawa, D. K. Sindelar, D. W. Neal, M. Burish, and A. D. Cherrington Interaction of free fatty acids and epinephrine in regulating hepatic glucose production in conscious dogs Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E291 - E301. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Goldstein, L. Rossetti, B. A. J. Palmer, R. Liu, D. Massillon, M. Scott, D. Neal, P. Williams, B. Peeler, and A. D. Cherrington Effects of fasting and glucocorticoids on hepatic gluconeogenesis assessed using two independent methods in vivo Am J Physiol Endocrinol Metab, November 1, 2002; 283(5): E946 - E957. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cardin, K. Walmsley, D. W. Neal, P. E. Williams, and A. D. Cherrington Involvement of the vagus nerves in the regulation of basal hepatic glucose production in conscious dogs Am J Physiol Endocrinol Metab, November 1, 2002; 283(5): E958 - E964. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vicini, A. Avogaro, M. E. Spilker, A. Gallo, and C. Cobelli Epinephrine effects on insulin-glucose dynamics: the labeled IVGTT two-compartment minimal model approach Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E78 - E84. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Coker, Y. Koyama, J. C. Denny, R. C. Camacho, D. B. Lacy, and D. H. Wasserman Prevention of Overt Hypoglycemia During Exercise: Stimulation of Endogenous Glucose Production Independent of Hepatic Catecholamine Action and Changes in Pancreatic Hormone Concentration Diabetes, May 1, 2002; 51(5): 1310 - 1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. Nielsen, J. O. Clemmesen, C. Skak, P. Ott, and N. H. Secher Attenuated hepatosplanchnic uptake of lactate during intense exercise in humans J Appl Physiol, April 1, 2002; 92(4): 1677 - 1683. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Manthous Lactic Acidosis in Status Asthmaticus : Three Cases and Review of the Literature Chest, May 1, 2001; 119(5): 1599 - 1602. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Mittelman and R. N. Bergman Inhibition of lipolysis causes suppression of endogenous glucose production independent of changes in insulin Am J Physiol Endocrinol Metab, September 1, 2000; 279(3): E630 - E637. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Chu, D. K. Sindelar, K. Igawa, S. Sherck, D. W. Neal, M. Emshwiller, and A. D. Cherrington The direct effects of catecholamines on hepatic glucose production occur via alpha 1- and beta 2-receptors in the dog Am J Physiol Endocrinol Metab, August 1, 2000; 279(2): E463 - E473. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Kreisman, N. A. Mew, M. Arsenault, S. J. Nessim, J. B. Halter, M. Vranic, and E. B. Marliss Epinephrine infusion during moderate intensity exercise increases glucose production and uptake Am J Physiol Endocrinol Metab, May 1, 2000; 278(5): E949 - E957. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Weber and D. S. Shanghavi Regulation of glucose production in rainbow trout: role of epinephrine in vivo and in isolated hepatocytes Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2000; 278(4): R956 - R963. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Lekas, S. J. Fisher, B. El-Bahrani, M. van Delangeryt, M. Vranic, and Z. Q. Shi Glucose uptake during centrally induced stress is insulin independent and enhanced by adrenergic blockade J Appl Physiol, August 1, 1999; 87(2): 722 - 731. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Cersosimo, I. N. Zaitseva, and M. Ajmal Effects of beta -adrenergic blockade on hepatic and renal glucose production during hypoglycemia in conscious dogs Am J Physiol Endocrinol Metab, November 1, 1998; 275(5): E792 - E797. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Laurent, K. F. Petersen, R. R. Russell, G. W. Cline, and G. I. Shulman Effect of epinephrine on muscle glycogenolysis and insulin-stimulated muscle glycogen synthesis in humans Am J Physiol Endocrinol Metab, January 1, 1998; 274(1): E130 - E138. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Chu, D. K. Sindelar, D. W. Neal, E. J. Allen, E. P. Donahue, and A. D. Cherrington Effect of a selective rise in sinusoidal norepinephrine on HGP is due to an increase in glycogenolysis Am J Physiol Endocrinol Metab, January 1, 1998; 274(1): E162 - E171. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. P. McGuinness, V. Shau, E. M. Benson, M. Lewis, R. T. Snowden, J. E. Greene, D. W. Neal, and A. D. Cherrington Role of epinephrine and norepinephrine in the metabolic response to stress hormone infusion in the conscious dog Am J Physiol Endocrinol Metab, October 1, 1997; 273(4): E674 - E681. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Coker, M. G. Krishna, D. B. Lacy, E. J. Allen, and D. H. Wasserman Sympathetic drive to liver and nonhepatic splanchnic tissue during heavy exercise J Appl Physiol, April 1, 1997; 82(4): 1244 - 1249. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |